leadf
logo-loader
AIM:ONC FRA:OCY

Oncimmune Holdings PLC

Receive alerts
Market:
AIM
Market Cap:
£120.96 m
Price
175.00 GBX
Change
-2.78%
52 weeks high
261.63
52 weeks low
142.50

In brief

Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases.

The company's growing range of diagnostic products can detect early-stage cancer and our service-based platform, delivers actionable insights into therapies to our pharmaceutical and biotech partners.

Snapshot

  • Oncimmune signs agreement with big pharma group for autoimmune diseases profiling
  • Oncimmune Holdings' full trading update in line with market expectations